Product name:Mupirocin(BRL-4910A;pseudomonas acid A)
Description: Mupirocin, also known as pseudomonas acid A, is an ideal skin surface antibacterial preparation. It was marketed by GlaxoSmithKline under the trade name of "Bactroban" in 1985 . The US FDA approved the drug to be used in the United States in 1987, and my country approved the production and sale of the drug in 1993 by Sino-American Schick Pharmaceuticals. Mupirocin is mainly used to prevent and treat skin bacterial infections caused by gram-positive cocci, such as impetigo, boils, folliculitis and other primary skin infections, as well as eczema co-infection, ulcer co-infection, and trauma co-infection Infection and other secondary skin infections. The main mechanism of mupirocin's antibacterial effect is to inhibit protein synthesis in bacteria.